Table 4.
Compound | Inhibitory efficiency (observed activity)a | Classification (by observed activity) | Calculated pFAR (Predicted activity) | Classification (by predicted activity) |
---|---|---|---|---|
Naringenin | 56.93 | Active inhibitor | −0.39 | Active inhibitorb |
Quercetin | 72.73 | Active inhibitor | −0.04 | Active inhibitorb |
Morin | 56.63 | Active inhibitor | −0.07 | Active inhibitorc |
Silymarin | 60 | Active inhibitor | 0.42 | Inducerc |
Epigallocatechin gallate (EGCG) | 168.18 | Strong inhibitor | −1.03 | Strong inhibitord |
Epicatechin gallate (ECG) | 95.45 | Active inhibitor | −0.61 | Active inhibitord |
Biochenin A | 198.04 | Strong inhibitor | −1.30 | Strong inhibitorb |
Hesperidin | 164.41 | Strong inhibitor | −1.32 | Strong inhibitore |
Demethylnobiletin | 87.43 | Active inhibitor | −1.13 | Strong inhibitore |
5HHMF | 65.47 | Active inhibitor | 0.44 | Inducere |
Nobiletin | 45.71 | Active inhibitor | 1.58 | Inducere |
Positive control (verapamil) | 100 | Strong inhibitor | – | – |